Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry
Results 3521 - 500 out of 500 displayed.
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Reset ↻

Daré Bioscience Reports Full Year 2023 Financial Results and Provides Company Update

Read more ››

By: GlobeNewswire - 28 Mar 2024

Related companies: Daré Bioscience, Inc.

American Oncology Network Announces Attendance and Participation at Leading Community Oncology Conference

Read more ››

By: GlobeNewswire - 28 Mar 2024

Related companies: American Oncology Network, LLC

Sofwave Medical to Participate in the Needham 23rd Annual Healthcare Conference

Read more ››

By: GlobeNewswire - 28 Mar 2024

Arcutis to Present at the 23rd Annual Needham Virtual Healthcare Conference

Read more ››

By: GlobeNewswire - 28 Mar 2024

Related companies: Arcutis Biotherapeutics, Inc.

BrainsWay Announces Positive Results in Late-Life Depression Post-Marketing Analysis

Read more ››

By: GlobeNewswire - 28 Mar 2024

Related companies: Brainsway Ltd.

Reviva to Present RECOVER Phase 3 Clinical Trial Data for Brilaroxazine in Schizophrenia at the SIRS 2024 Annual Meeting

Read more ››

By: GlobeNewswire - 28 Mar 2024

Related companies: Reviva Pharmaceuticals, Inc.

IMUNON Reports 2023 Financial Results and Provides Business Update

Read more ››

By: GlobeNewswire - 28 Mar 2024

Related companies: Imunon, Inc

Larkspur Biosciences to Present New Preclinical Research on Lead Development Program Candidate, a First-in-Class PIP4K2C Protein Degrader, at AACR 2024

Read more ››

By: GlobeNewswire - 28 Mar 2024

Related companies: Larkspur Biosciences Inc.

4DMT Announces Update on Regulatory Interactions and Development Path for 4D-710 for Treatment of Cystic Fibrosis

Read more ››

By: GlobeNewswire - 28 Mar 2024

Related companies: 4D Molecular Therapeutics, Inc.

Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

Read more ››

By: GlobeNewswire - 28 Mar 2024

Related companies: Cocrystal Pharma, Inc.

CG Oncology to Present Results on Cretostimogene at the AUA 2024 Annual Meeting

Read more ››

By: GlobeNewswire - 28 Mar 2024

Related companies: CG Oncology, Inc.

Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors

Read more ››

By: GlobeNewswire - 28 Mar 2024

Related companies: COMPASS Pathways plc

Lowell Farms Inc. Announces Audited Fourth Quarter and Fiscal Year 2023 Financial and Operational Results

Read more ››

By: GlobeNewswire - 28 Mar 2024

Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL

Read more ››

By: GlobeNewswire - 28 Mar 2024

Related companies: Ocean Biomedical Inc.

Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day

Read more ››

By: GlobeNewswire - 28 Mar 2024

Related companies: Catalyst Pharmaceuticals, Inc.

Tevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conversion Price

Read more ››

By: GlobeNewswire - 28 Mar 2024

Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update

Read more ››

By: GlobeNewswire - 28 Mar 2024

Related companies: Agile Therapeutics, Inc.

AIM ImmunoTech to Present at the MedInvest Biotech & Pharma Investor Conference

Read more ››

By: GlobeNewswire - 28 Mar 2024

Related companies: AIM ImmunoTech Inc.

Candel Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Highlights

Read more ››

By: GlobeNewswire - 28 Mar 2024

Related companies: Candel Therapeutics, Inc.

Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement

Read more ››

By: GlobeNewswire - 28 Mar 2024

Related companies: Molecular Templates, Inc.

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

to the top ↑